Omada Health (NASDAQ:OMDA) Stock Price Target Cut by Wells Fargo & Company

Omada Health (NASDAQ:OMDA) had its target price reduced by research analysts at Wells Fargo & Company from $22.00 to $19.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target would indicate a potential upside of 25.91% from the stock’s previous close.

OMDA has been the subject of several other research reports. JPMorgan Chase & Co. boosted their target price on Omada Health from $26.00 to $30.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Citigroup restated an “outperform” rating on shares of Omada Health in a research note on Friday, August 14th. Wall Street Zen upgraded shares of Omada Health from a “hold” rating to a “buy” rating in a research report on Sunday, October 11th. Zacks Research cut shares of Omada Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Finally, Canaccord Genuity Group increased their price objective on shares of Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a research note on Tuesday, July 21st. Eleven analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Omada Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.33.

Omada Health Price Performance

OMDA stock opened at $15.09 on Friday. The stock has a market capitalization of $923.81 million, a price-to-earnings ratio of 71.86 and a beta of 2.13. The business’s fifty day moving average price is $20.14 and its two-hundred day moving average price is $17.74. Omada Health has a fifty-two week low of $10.28 and a fifty-two week high of $25.45.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.08. The company had revenue of $91.31 million during the quarter. Omada Health had a net margin of 4.21% and a return on equity of 5.91%. Research analysts expect that Omada Health will post 0.09 EPS for the current year.

Insiders Place Their Bets

In related news, CAO Craig Gracey sold 1,042 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $25.00, for a total transaction of $26,050.00. Following the transaction, the chief accounting officer owned 15,441 shares in the company, valued at $386,025. The trade was a 6.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Steven Cook sold 6,800 shares of the stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $21.86, for a total value of $148,648.00. Following the completion of the transaction, the chief financial officer owned 173,906 shares in the company, valued at approximately $3,801,585.16. The trade was a 3.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 119,014 shares of company stock valued at $2,711,405. Company insiders own 6.38% of the company’s stock.

Institutional Investors Weigh In On Omada Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Sterling Capital Management LLC lifted its position in Omada Health by 1,161.6% in the 3rd quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock worth $33,000 after buying an additional 1,452 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new stake in Omada Health in the second quarter worth approximately $53,000. State of Alaska Department of Revenue purchased a new stake in Omada Health in the third quarter worth approximately $59,000. Versant Capital Management Inc grew its position in Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after acquiring an additional 2,283 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. bought a new position in Omada Health during the third quarter valued at approximately $70,000.

More Omada Health News

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Omada reported Q3 revenue of $91 million, up 34% year over year, and total members grew 36% to a record 1.1 million. Net income was $7 million versus a year-ago loss, while adjusted EBITDA increased to $12 million. The company also raised its full-year 2026 financial outlook. Omada Health Reports Third Quarter 2026 Results
• Positive Sentiment: Quarterly revenue exceeded FactSet’s estimate, and reported earnings also topped consensus estimates, providing evidence of stronger-than-expected operating performance. Earnings Flash: Q3 Revenue
• Neutral Sentiment: Unusual options activity was reported after Omada’s earnings, signaling heightened trading interest but not indicating a clear direction for the stock. Unusual Options Volume Report
• Negative Sentiment: Several analysts took a more cautious stance: Wells Fargo cut its price target to $19 and maintained an “equal weight” rating, while Zacks Research downgraded OMDA from “strong buy” to “hold.” Wells Fargo analyst actions Zacks Research analyst action
• Negative Sentiment: Barclays also lowered its target from $24 to $22, although it retained an “overweight” rating. Barclays analyst action

About Omada Health

Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.